Skip to main content
Neuro-Ophthalmology logoLink to Neuro-Ophthalmology
. 2019 Mar 14;43(6):371–374. doi: 10.1080/01658107.2019.1588337

Lack of Relationship between Central Corneal Thickness and Papilloedema in Idiopathic Intracranial Hypertension

Jason H Peragallo a,b,, Caroline Vasseneix a, Michael Dattilo a, Nancy J Newman a,c,d, Valérie Biousse a,c, Beau B Bruce a,c,e
PMCID: PMC7053948  PMID: 32165895

ABSTRACT

Translaminar pressure gradient abnormalities have been implicated in the pathogenesis and progression of glaucoma. A “reversed” translaminar pressure gradient may be related to papilloedema severity in idiopathic intracranial hypertension. Central corneal thickness is related to intraocular pressure measurements and, by extension, to translaminar pressure gradients. We evaluated if central corneal thickness could be a marker of worse papilloedema due to altered translaminar pressure gradients in patients with idiopathic intracranial hypertension. We found that central corneal thickness was not related to the severity of papilloedema in idiopathic intracranial hypertension.

KEYWORDS: Central corneal thickness, translaminar pressure gradient, idiopathic intracranial hypertension, glaucoma

Introduction

Idiopathic intracranial hypertension (IIH), a disorder of elevated intracranial pressure without an identifiable cause, can lead to vision loss when increased pressure is transmitted to the anterior portion of the optic nerves causing papilloedema. The translaminar pressure gradient (TLPG), the difference between intraocular pressure (IOP) and intracranial pressure across the lamina cribrosa, may play a role in the pathophysiology underlying IIH and glaucoma, a disorder related to elevated IOP. Central corneal thickness (CCT) is an important metric in the evaluation of IOP and the risk of glaucoma.1 Patients with thinner CCTs have higher true intraocular pressures than those measured by applanation tonometry (and are therefore at higher risk for developing primary open-angle glaucoma) because tonometers are constructed to measure IOP with an assumed normal corneal thickness. CCT influences IOP measurements and, by extension, TLPG measurements. Since the TLPG may influence the severity of optic nerve head damage in glaucoma,2,3 it is possible that a “reversed” TLPG may influence the severity of papilloedema in IIH.4 Therefore CCT, via its effect on IOP measurement, could be a marker of worse papilloedema in patients with IIH.

Methods

Participants

The Institutional Review Board of Emory University approved this study. We retrospectively reviewed the medical records of 100 consecutive patients diagnosed with IIH who had systematic CCT measurements between March 2015 and October 2016. Diagnosis of IIH was made using the updated modified Dandy criteria.5 Patients were excluded if the diagnosis of IIH was uncertain or if they presented with corneal disease that could modify CCT. Glaucoma patients were excluded.

Data collected included age, demographics, medications, body mass index (BMI), IOP, cerebrospinal fluid opening pressure (CSF-OP) measured by lumbar puncture at the time of diagnosis (before initiation of treatment), visual acuity, colour vision, CCT, visual fields, and Frisén grade of papilloedema. Visual fields were graded as 0 = normal, 1 = enlarged blind spot, 2 = generalised depression, 3 = arcuate nerve fibre bundle defect, 4 = altitudinal defect, 5 = neurologic-like/other, 6 = central scotoma.

CCT was determined using handheld ultrasound pachymetry (DGH 550 Pachette 2, DGH Technology Inc., Exton, PA). The mean value of two readings was calculated for each eye. TLPGs were calculated by determining the difference between IOP and CSF-OP (following conversion of CSF-OP from cmH2O to mmHg).

Statistical analysis

Controlling for age, race and sex, we examined associations between CCT and other variables of interest: BMI, CSF-OP, follow-up in months, visual acuity and visual field defects (at initial and final examinations), colour vision, IOP, TLPG, Frisén grade of papilloedema, and presence of papilloedema and/or optic nerve pallor (at initial and final examinations).

We used the following generalised estimating equation models to account for intereye correlations: linear for CSF-OP, CCT, cup-to-disc ratio, colour vision, IOP and TLPG; logistic for Frisén grade ≤4, visual field defects at initial and final examinations, papilloedema or optic nerve pallor at initial and final visits; and ordinal for Frisén grade and visual field comparison between initial and final visit.

Results

Two-hundred eyes of 100 patients with IIH were included (median age at diagnosis 31.4 years [interquartile range 24.8–36.1]) [Table 1]. Patients had a median visual acuity of 0.0 logMAR at initial and final examinations.

Table 1.

Characteristics of 100 patients with idiopathic intracranial hypertension.

Characteristics Value
Median age 31.4 years (IQR 24.8–36.1)
Gender 95/100 women (95%)
Race 56/100 black (56%)
35/100 white (35%)
Median follow-up 10.7 months (IQR 1.6–20.2)
Median BMI 35.7 kg/m2 (IQR 31.1–43)
Median CSF opening pressure 34 cmH2O (IQR 29.6–41.7)
Median CCT 552 μm (IQR 527.5–577.5)
Median IOP 15 mmHg (IQR 13–17)
Median TLPG (CSF OP-IOP) 9.4 mmHg (IQR 6.4–16.9)
Presence of papilloedema at presentation 142/200 eyes (71%)
Frisén Grade 1 39/142 eyes (20%)
Frisén Grade 2 39/142 eyes (20%)
Frisén Grade 3 40/142 eyes (20%)
Frisén Grade 4 16/142 eyes (8%)
Frisén Grade 5 8/142 eyes (4%)
Optic nerve pallor at presentation 30/200 eyes (15%)
Optic nerve pallor at final visit 43/170 eyes (25%)
Visual field defect at presentation 70/193 (36%)
Visual field defect at final visit 60/163 (36%)

IQR: interquartile range, BMI: body max index, CSF: cerebrospinal fluid, OP: opening pressure, CCT: central corneal thickness, IOP: intraocular pressure, TLPG: translaminar pressure gradient (gradient across lamina cribrosa).

Controlling for age, race and sex, CCT was not associated with any of the studied variables. No correlation was found between CCT and IOP, BMI, or TLPG. CCT was not associated with CSF-OP (Figure 1), severity of papilloedema, or optic nerve pallor at initial or final examinations. There was no correlation between CCT and final visual acuity or visual field defects [Table 2].

Figure 1.

Figure 1.

Representative illustration of the overall study results: Scatter plot showing the correlation between central corneal thickness (CCT) and CSF opening pressure. No correlation was found between CCT and CSF opening pressure (r = 0.00).

Table 2.

Association between central corneal thickness and listed variables controlling for age, sex, and race.

Variable Mean change in CCT, μm (standard error) p-Value
Frisén grade 4 or greater vs. lower grade −0.003 (0.006) 0.68
Optic nerve pallor −0.006 (0.006) 0.31
Visual acuity at final visit, per unit logMAR −0.007 (0.005) 0.12
Visual field deficit at final visit, grade 2 or higher vs. lower −0.008 (0.006) 0.16

Discussion

We found that the median CCT for patients with IIH was in the normal range. There were no correlations between CCT and CSF-OP, TLPG, severity of papilloedema, or visual outcomes. However, it is not currently possible to directly measure TLPG in humans, as has been mentioned in a recent study evaluating IOP and CSF-OP in IIH patients on acetazolamide.6 This paper also used the difference between IOP and CSF-OP as a surrogate marker for direct TLPG measurement. However, opening pressure in the lumbar spine may not reflect the pressure in the immediate retrolaminar space due to CSF compartmentalisation, leading to incorrect assumptions about the actual TLPG.7 Further studies are necessary to evaluate the relationships among CCT, TLPG, IIH, and glaucoma. Although this was a negative study, we know CCT is an important variable in glaucoma, and we suspect TLPG is a factor in glaucoma severity. Due to the influence of CCT on IOP measurements, CCT may still change TLPG. Considering CCT as a variable in future studies may therefore be important in IIH studies involving TLPG.

Funding Statement

This work was supported in part by an unrestricted departmental grant (Department of Ophthalmology) from Research to Prevent Blindness, Inc., New York; and by NIH/National Eye Institute [P30-EY06360].

Declaration of interest

The authors report no conflicts of interest.

References

  • 1.Gordon MO, Beiser JA, Brandt JD, et al. 2nd, Wilson MR, Kass MA. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002. June;120(6):714–720. doi: 10.1001/archopht.120.6.714. [DOI] [PubMed] [Google Scholar]
  • 2.Guy AH, Wiggs JL, Turalba A, Pasquale LR.. Translating the low translaminar cribrosa pressure gradient hypothesis into the clinical care of glaucoma. Semin Ophthalmol. 2016;31(1–2):131–139. doi: 10.3109/08820538.2015.1114855. [DOI] [PubMed] [Google Scholar]
  • 3.McCulley TJ, Chang JR, Piluek WJ. Intracranial pressure and glaucoma. J Neuroophthalmol. 2015;35(Suppl 1):S38–S44. doi: 10.1097/WNO.0000000000000295. [DOI] [PubMed] [Google Scholar]
  • 4.Morgan WH, Balaratnasingam C, Lind CR, et al. Cerebrospinal fluid pressure and the eye. Br J Ophthalmol. 2016;100(1):71–77. doi: 10.1136/bjophthalmol-2015-306705. [DOI] [PubMed] [Google Scholar]
  • 5.Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–1165. [DOI] [PubMed] [Google Scholar]
  • 6.Banik R, Kupersmith MJ, Wang JK, Garvin MK. NORDIC idiopathic intracranial hypertension study group. The effect of acetazolamide and weight loss on intraocular pressure in idiopathic intracranial hypertension patients [published online ahead of print January 7, 2019]. J Glaucoma. doi: 10.1097/IJG.0000000000001189. [DOI] [PubMed] [Google Scholar]
  • 7.Killer HE, Pircher A. What do we really know about translaminar pressure? J Neuroophthalmol. 2016;36(1):110–111. doi: 10.1097/WNO.0000000000000365. [DOI] [PubMed] [Google Scholar]

Articles from Neuro-Ophthalmology are provided here courtesy of Taylor & Francis

RESOURCES